Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.72 | 12.24 |
| PEG Ratio (TTM) | -1.71 | 9.74 |
| P/S Ratio (TTM) | 0.48 | 2.46 |
| P/B Ratio (TTM) | 0.89 | 5.39 |
| P/FCF Ratio (TTM) | 9.08 | 18.08 |
| Price to 5YR AVG Earnings Ratio | 17.88 | 24.29 |
| Price to 5YR AVG FCF Ratio | 19.51 | 19.97 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.20% | 6.96% |
| ROE (TTM) | 6.15% | 23.34% |
| Net Profit Margin (TTM) | 2.85% | 10.41% |
| ROIC 5YR AVG | 12.41% | -27.41% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 41.34% | 124.07% | 72.28% |
| Revenue | -0.12% | 6.76% | 5.45% |
| Net Income | 38.67% | 155.24% | 91.37% |
| Cash Flow | 1,172.17% | 298.32% | 206.54% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.81 | 1.94 |
| Quick Ratio (TTM) | 1.06 | 1.46 |
| D/E Ratio (TTM) | 0.62 | 1.83 |
| Interest Coverage (TTM) | 8.88 | 12.96 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.63 | 4.35 |
| LTL to 5YR AVG FCF | 9.23 | 1.58 |
| Shares Outstanding Growth 5YR AVG | 3.86% | 4.00% |